Article info

Download PDFPDF
Weekly carboplatin and paclitaxel is safe, active, and well tolerated in recurrent ovarian cancer cases of Japanese women previously treated with cisplatin-containing multidrug chemotherapy

Authors

  1. Address correspondence and reprint requests to: Hideki Sakamoto, MD, PhD, Associate Professor Obstetrics and Gynecology, Nihon University School of Medicine, 30-1 Oyaguchi, Kamimachi, Itabashi, Tokyo 173-8610, Japan. Email: sakamoto{at}med.nihon-u.ac.jp

Citation

Kikuchi A, Sakamoto H, Yamamoto T
Weekly carboplatin and paclitaxel is safe, active, and well tolerated in recurrent ovarian cancer cases of Japanese women previously treated with cisplatin-containing multidrug chemotherapy

Publication history

  • First published January 1, 2005.
Online issue publication 
January 01, 2005

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.